Triple-negative breast cancer (TNBC) is defined immunohistochemically by the deficiencies of three receptors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Here, ESR1 is linked to triple-negative breast carcinoma.